PECAM1 and Alzheimer disease: Furthermore, we hypothesized that the CHID1 expression levels in the AD patient brain samples were correlated with markers of microglial activation (IBA1), vascular integrity (CD31), and neuronal death (CALB1) and neurogranin (NRGN), all phenomena characterizing the brain of AD patients.